Notice Under Section 708A

Jul 28, 2026 at 2:19 AM EDT · Issued by Radiopharm Theranostics Limited via ASX

Filed with ASX · Jul 28, 2026 at 2:19 AM EDT

On 6ix: 6ix.com/news/notice-under-section-708a-22

Radiopharm Theranostics Limited Suite 1, Level 3, 62 Lygon Street, Carlton South VIC 3053 Australia ABN: 57 647 877 889 ASX ANNOUNCEMENT 28 July 2026 Notice Under Section 708A(5)(e) of the Corporations Act 2001 This notice is given by Radiopharm Theranostics Limited...

View Attachment

6ix hasn’t read this filing yet.

Radiopharm Theranostics Limited on 6ix

Earlier from Radiopharm Theranostics

Application for quotation of securities - RADJul 27
Radiopharm Theranostics Announces Concurrent US$4.1 Million Registered Direct Offering and Up to Additional A$12.7 (US$8.9) Million Australian Placement and Share Purchase PlanJul 27
RAD completes A$12.5 M placement and launches A$6 M SPPJul 24
Radiopharm Theranostics Achieves Confirmed Durable Partial Response in Ongoing Phase 1 Trial of RAD204 in Patients with Advanced Solid Tumors Post-ImmunotherapyJul 22
RAD Achieves Partial Response in Phase 1 Trial of RAD204Jul 21

Later from Radiopharm Theranostics

ProspectusJul 30
Target market determination (TMD)Jul 30
Change in substantial holdingJul 30
Quarterly Activities/Appendix 4C Cash Flow ReportJul 30
Update - Proposed issue of securities - RADAug 4

All Radiopharm Theranostics news releases

Follow Radiopharm Theranostics into a list and get an email when it puts out news.

Follow Radiopharm Theranostics